Hyperbaric oxygen therapy compared to... (2023 study) Skip to main content
RCT PLoS ONE 2023

Hyperbaric oxygen therapy compared to pharmacological intervention in fibromyalgia patients following traumatic brain injury: a randomized, controlled trial

Ablin JN, Lang E, Engel-Yeger B, et al., PLoS ONE, 2023

Tier 1, Curated

Manually reviewed and included in the Canada Hyperbarics research database.

Summary

What Researchers Did

Researchers randomly assigned people with fibromyalgia and a history of traumatic brain injury (TBI) to either hyperbaric oxygen therapy (HBOT) or medication (Pregabalin or Duloxetine) and compared the results.

What They Found

In this randomized controlled trial of fibromyalgia patients with a history of TBI, pain intensity on a visual analogue scale fell more with HBOT than with medication, with a significant group-by-time interaction (p = 0.001) and a large net effect size (d = -0.95). The HBOT group had 60 daily sessions of 100% oxygen by mask at 2 ATA for 90 minutes. The abstract reports significant improvements after HBOT in fibromyalgia symptom and pain questionnaires and in quality of life, along with higher pain thresholds and conditioned pain modulation. Brain imaging (SPECT) showed significant group-by-time differences between the groups in the left frontal and right temporal cortex.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract does not report the number of participants, whether participants or assessors were blinded, or how long benefits lasted after treatment, so the strength of the findings cannot be judged from the abstract alone.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type RCT
Category Neurological
Source Pubmed
PubMed ID 36897850
Year Published 2023
Journal PLoS ONE

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology